These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19707380)
1. New treatment options in the management of IBD - focus on colony stimulating factors. Barahona-Garrido J; Yamamoto-Furusho JK Biologics; 2008 Sep; 2(3):501-4. PubMed ID: 19707380 [TBL] [Abstract][Full Text] [Related]
2. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease. Däbritz J Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766 [TBL] [Abstract][Full Text] [Related]
4. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
5. Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility. Barahona-Garrido J; Hernández-Calleros J; García-Juárez I; Yamamoto-Furusho JK Saudi J Gastroenterol; 2009; 15(3):208-12. PubMed ID: 19636186 [TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Han X; Uchida K; Jurickova I; Koch D; Willson T; Samson C; Bonkowski E; Trauernicht A; Kim MO; Tomer G; Dubinsky M; Plevy S; Kugathsan S; Trapnell BC; Denson LA Gastroenterology; 2009 Apr; 136(4):1261-71, e1-3. PubMed ID: 19230854 [TBL] [Abstract][Full Text] [Related]
7. A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF. Chuang LS; Villaverde N; Hui KY; Mortha A; Rahman A; Levine AP; Haritunians T; Evelyn Ng SM; Zhang W; Hsu NY; Facey JA; Luong T; Fernandez-Hernandez H; Li D; Rivas M; Schiff ER; Gusev A; Schumm LP; Bowen BM; Sharma Y; Ning K; Remark R; Gnjatic S; Legnani P; George J; Sands BE; Stempak JM; Datta LW; Lipka S; Katz S; Cheifetz AS; Barzilai N; Pontikos N; Abraham C; Dubinsky MJ; Targan S; Taylor K; Rotter JI; Scherl EJ; Desnick RJ; Abreu MT; Zhao H; Atzmon G; Pe'er I; Kugathasan S; Hakonarson H; McCauley JL; Lencz T; Darvasi A; Plagnol V; Silverberg MS; Muise AM; Brant SR; Daly MJ; Segal AW; Duerr RH; Merad M; McGovern DP; Peter I; Cho JH Gastroenterology; 2016 Oct; 151(4):710-723.e2. PubMed ID: 27377463 [TBL] [Abstract][Full Text] [Related]
8. Sargramostim (GM-CSF) for induction of remission in Crohn's disease. Roth L; Macdonald JK; McDonald JW; Chande N Cochrane Database Syst Rev; 2011 Nov; (11):CD008538. PubMed ID: 22071853 [TBL] [Abstract][Full Text] [Related]
9. Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia. Heaney ML; Toy EL; Vekeman F; Laliberté F; Dority BL; Perlman D; Barghout V; Duh MS Cancer; 2009 Oct; 115(20):4839-48. PubMed ID: 19637341 [TBL] [Abstract][Full Text] [Related]
10. Increased GM-CSF-producing NCR Chang Y; Kim JW; Yang S; Chung DH; Ko JS; Moon JS; Kim HY Clin Transl Immunology; 2021; 10(7):e1311. PubMed ID: 34262760 [TBL] [Abstract][Full Text] [Related]
11. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369 [TBL] [Abstract][Full Text] [Related]
13. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease. Ina K; Kusugami K; Hosokawa T; Imada A; Shimizu T; Yamaguchi T; Ohsuga M; Kyokane K; Sakai T; Nishio Y; Yokoyama Y; Ando T J Gastroenterol Hepatol; 1999 Jan; 14(1):46-53. PubMed ID: 10029277 [TBL] [Abstract][Full Text] [Related]
14. Alpha-defensins in the gastrointestinal tract. Cunliffe RN Mol Immunol; 2003 Nov; 40(7):463-7. PubMed ID: 14568393 [TBL] [Abstract][Full Text] [Related]
15. GM-CSF and the role of myeloid regulatory cells in the pathogenesis and treatment of Crohn's disease. Däbritz J Mol Cell Pediatr; 2015 Dec; 2(1):12. PubMed ID: 26626346 [TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253 [TBL] [Abstract][Full Text] [Related]
17. Immediate hypersensitivity to human recombinant granulocyte-macrophage colony-stimulating factor associated with a positive prick skin test reaction. Engler RJ; Weiss RB Ann Allergy Asthma Immunol; 1996 Jun; 76(6):531-4. PubMed ID: 8673688 [TBL] [Abstract][Full Text] [Related]
18. Colony-stimulating factors: beyond the effects on hematopoiesis. Stull DM Am J Health Syst Pharm; 2002 Apr; 59(7 Suppl 2):S12-20. PubMed ID: 11944610 [TBL] [Abstract][Full Text] [Related]